Trial
NCT03596073
Topical Calcipotriene Treatment for Breast Cancer Immunoprevention
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Breast Cancer
Intervention
Topical Calcipotriene Ointment
Why stopped
Interim analysis did not show the required cytokine induction by topical calcipotriene to justify continuation of the trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-07